106 related articles for article (PubMed ID: 8578768)
1. Pharmacokinetics and tolerance of a new fluoroquinolone antimicrobial drug after single oral doses in healthy volunteers.
Tanaka M; Tamura K; Atarashi S; Kubo Y; Oliver SD; Bentley M; Hakusui H
Xenobiotica; 1995 Nov; 25(10):1119-25. PubMed ID: 8578768
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
[TBL] [Abstract][Full Text] [Related]
3. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects.
Stass H; Dalhoff A; Kubitza D; Schühly U
Antimicrob Agents Chemother; 1998 Aug; 42(8):2060-5. PubMed ID: 9687407
[TBL] [Abstract][Full Text] [Related]
5. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
[TBL] [Abstract][Full Text] [Related]
6. Effect of Maalox on the oral absorption of sparfloxacin.
Johnson RD; Dorr MB; Talbot GH; Caille G
Clin Ther; 1998; 20(6):1149-58. PubMed ID: 9916608
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and safety of single oral doses of lomefloxacin.
Morse IS
Biopharm Drug Dispos; 1990; 11(6):543-51. PubMed ID: 2207304
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.
Picollo R; Brion N; Gualano V; Millérioux L; Marchetti M; Rosignoli MT; Dionisio P
Arzneimittelforschung; 2003; 53(3):201-5. PubMed ID: 12705176
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg.
Montay G; Bruno R; Vergniol JC; Ebmeier M; Le Roux Y; Guimart C; Frydman A; Chassard D; Thebault JJ
J Clin Pharmacol; 1994 Nov; 34(11):1071-6. PubMed ID: 7876398
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
[TBL] [Abstract][Full Text] [Related]
12. Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.
Ritz M; Lode H; Fassbender M; Borner K; Koeppe P; Nord CE
Antimicrob Agents Chemother; 1994 Mar; 38(3):455-9. PubMed ID: 8203837
[TBL] [Abstract][Full Text] [Related]
13. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.
Nakashima M; Uematsu T; Kosuge K; Okuyama Y; Morino A; Ozaki M; Takebe Y
J Clin Pharmacol; 1994 Sep; 34(9):930-7. PubMed ID: 7983237
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and urinary excretion of DW116, a new fluoroquinolone antibacterial agent, in humans as a phase I study.
Jung BH; Choi MH; Chung BC
Drug Dev Ind Pharm; 2000 Jan; 26(1):103-6. PubMed ID: 10677817
[TBL] [Abstract][Full Text] [Related]
16. The influence of age and gender on the pharmacokinetics of moxifloxacin.
Sullivan JT; Lettieri JT; Liu P; Heller AH
Clin Pharmacokinet; 2001; 40 Suppl 1():11-8. PubMed ID: 11352437
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
[TBL] [Abstract][Full Text] [Related]
18. Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
Kisicki JC; Griess RS; Ott CL; Cohen GM; McCormack RJ; Troetel WM; Imbimbo BP
Antimicrob Agents Chemother; 1992 Jun; 36(6):1296-301. PubMed ID: 1329618
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of temafloxacin in humans after multiple oral doses.
Granneman GR; Carpentier P; Morrison PJ; Pernet AG
Antimicrob Agents Chemother; 1992 Feb; 36(2):378-86. PubMed ID: 1318680
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
